GGrantIndex
← Leaderboards

Kenneth A Christensen

Clemson University

$1,261,527
Attributed
$3,253,323
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $609.6K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$3,253,323 · 5

By mechanism

R01$1,915,091 · 1
R21$1,250,025 · 3
R03$88,207 · 1

Top collaborators

Most similar at Clemson University

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsGlucose MetabolismSmall MoleculeGlycosomePathway InteractionsParasitesTrypanosoma Brucei BruceiMetabolismSensorAreaCellsMonitorSeriesGlycolysisGlucoseMetabolic PathwayMethodologyMetabolicRecombinantsIn VitroOrganismLeadBiologyGlucose Uptake

Grant awards (14)

Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$518,827
R01 · FY2024 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$66,149
R01 · FY2024 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$524,577
R01 · FY2023 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$66,149
R01 · FY2023 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$18,826
R01 · FY2023 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$497,486
R01 · FY2022 · AI
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis$223,077
R01 · FY2021 · AI
Identification of kinetoplastid parasite glucose uptake and subcellular localization inhibitors as therapeutic leads$271,486
R21 · FY2018 · AI
Identification of kinetoplastid parasite glucose uptake and subcellular localization inhibitors as therapeutic leads$184,138
R21 · FY2017 · AI
Phage Display Selection of Antiangiogenic CMG2 Cyclic Peptide Antagonists$197,854
R21 · FY2015 · EY · contact PI
pH and glucose sensing in Trypanosoma brucei glycosomes$183,936
R21 · FY2015 · AI · contact PI
Phage Display Selection of Antiangiogenic CMG2 Cyclic Peptide Antagonists$214,590
R21 · FY2014 · EY · contact PI
pH and glucose sensing in Trypanosoma brucei glycosomes$198,021
R21 · FY2014 · AI · contact PI
Assay:Molecules that Inhibit Anthrax Intoxication(RMI)$88,207
R03 · FY2005 · NS